Earnings Feed
Start Free
Home/Filings/4/0001181431-08-066067
4//SEC Filing

INDEVUS PHARMACEUTICALS INC 4

Accession 0001181431-08-066067

CIK 0000854222operating
View on SEC.govCompany Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:10 PM ET

Size

16.7 KB

Accession

0001181431-08-066067

Insider Transaction Report

Form 4
Period: 2008-12-04
INDEVUS PHARMACEUTICALS INCIDEV
BUTLER MARK S
Executive Vice President
Transactions
  • Award

    Stock Option (Right to Buy)

    2008-12-04+60,000→ 60,000 total
    Exercise: $5.00Exp: 2010-06-10→ Common Stock, $.001 par value per share (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2008-12-04−60,000→ 0 total
    Exercise: $5.00Exp: 2009-06-10→ Common Stock, $.001 par value per share (60,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2008-12-04−550,000→ 0 total
    Exercise: $6.19Exp: 2009-06-10→ Common Stock, $.001 par value per share (550,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2008-12-04+550,000→ 550,000 total
    Exercise: $6.19Exp: 2010-06-10→ Common Stock, $.001 par value per share (550,000 underlying)
Footnotes (3)
  • [F1]All of the reported transactions involved the amendment of outstanding stock options to extend the respective expiration dates from 6/10/2009 to 6/10/2010; such extensions are considered by the Securities and Exchange Commission to be cancellations of the current stock options.
  • [F2]Prior to the extension of the current stock option, such stock option was fully exercisable.
  • [F3]This stock option is fully exercisable as of the date of this report.

Documents

1 file

Issuer

INDEVUS PHARMACEUTICALS INC

CIK 0000854222

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000854222

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:10 PM ET
Size
16.7 KB
View on SEC.gov